Australia's largest stock trading and investment forum Australia's #1 stock forum

SP1

Click for more information

0.00%

$1.07 southern cross payments ltd

Ann: Prospectus, page-102

First 102 Last

Share
Profile

Follow
bgtaylo

3,806 Posts.

555

27/09/21

12:06

Post #: 56372295
Share

Originally posted by Treba: ↑

Not disagreeing there. But how does APT valuation effect ISX holding on a totally different exchange?

This is not an argument about because APT or Z1P are in excess of fundamentals that the ISX SP will also be.
This is about shareholders having a REASONABLE valuation and therefore reasonable expectation of the future. Its not $1.07 or $10.7.

(Obviously by the posters question there are alot of holders that do not understand the simplicity of this being a totally new listing and therefore new market valuation)

If it lists above the fundamental value that is a bonus.
But if shareholders are expecting it to list above (at $10.7 or above) it will not end well for them.

Most understand that short term paper losses is a very high chance of occuring but the chance for the company to grow is the silver lining.

Expand

I’m just saying find me a stock that is reasonably priced based on fundamentals in this space. I’d love to know . Everything is ridiculously overpriced , why would ISX be different. Not saying ISX will be too . But when in Rome. (No debt/net profit/runway etc etc).
Throw in a couple big announcements from management to boot = off to the races, in Europe’s negative yielding environment.

ISX Price at posting: $1.07 Sentiment: None Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 7 more messages in this thread...

First 102 Last

Add SP1 (ASX) to my watchlist